Lazard Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Lazard Asset Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-951	Closed	-$31K	–	2509
2021 Q3	$31K	Buy	+951	New	+$35.5K	﹤0.01%	1880
2020 Q4	–	Sell	-1,210	Closed	-$47K	–	2028
2020 Q3	$47K	Sell	1,210 -473	-28%	-$15.3K	﹤0.01%	1204
2020 Q2	$53K	Buy	1,683 +398	+31%	+$14.9K	﹤0.01%	1215
2020 Q1	$45K	Buy	+1,285	New	+$54.2K	﹤0.01%	1218
2015 Q3	–	Sell	-2,690	Closed	-$71K	–	1179
2015 Q2	$71K	Buy	2,690 +260	+11%	+$8.4K	﹤0.01%	946
2015 Q1	$94K	Buy	2,430 +2,095	+625%	+$72.2K	﹤0.01%	925
2014 Q4	$10K	Hold	335	–	–	﹤0.01%	1083
2014 Q3	$7K	Buy	+335	New	+$9.53K	﹤0.01%	996

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Lazard Asset Management's CSII Position: Q4 2021 in Review

Lazard Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 951 shares — an estimated $31K sold.

Lazard Asset Management first reported a position in CSII in Q3 2014 and held it in 8 quarters. The position peaked at $94K in Q1 2015. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

Lazard Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
Lazard Asset Management sold 951 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $31K.
Lazard Asset Management first reported a position in Cardiovascular Systems, Inc. in Q3 2014 and held it in 8 quarters.
Lazard Asset Management's Cardiovascular Systems, Inc. position peaked at $94K in Q1 2015.
167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.